Access Free Educational Videos and Webinars Provided by the Multiple Sclerosis Association of America
CHERRY HILL, N.J., June 25, 2025 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care partners. One of the many MSAA resources available is the Multiple Sclerosis Information (MSi) Video Library. This extensive library features a growing collection of content including webinars, educational videos, and recorded programs that are invaluable to the MS community. MSAA's webinars and videos cover pressing topics, which include understanding MS, lifestyle challenges, symptom management, health equities and diversity, as well as other vital topics. These resources provide an immeasurable wealth of knowledge and empowerment, accessible right from the comfort of viewers' homes.
With MSAA's mission of Improving Lives Today, we strive to ensure the MS community feels supported and equipped with educational resources to help with navigating their journey with MS. "Knowledge is power, especially when living with a complex condition such as multiple sclerosis," says Gina Ross Murdoch, President and CEO of MSAA. "Our video library is designed to deliver accessible, high-quality information from trusted sources, helping people to better understand and manage an MS diagnosis."
This on-demand video library is optimized for both mobile and desktop devices and includes transcripts of programs to ensure accessibility to all viewers. Users can easily browse by category to find content tailored to their specific interests and needs. To view MSAA's MSi Video Library, please visit MSAA's website at mymsaa.org/videos.
For more information regarding MSAA's Multiple Sclerosis Information Video Library, please contact Diana Cruz-Beniquez, Manager of Public Relations & Engagement, at (800) 532-7667, ext. 103, or via email at dcruz@mymsaa.org.
About MSAA The Multiple Sclerosis Association of America (MSAA) is a national nonprofit organization and leading resource for the entire MS community, improving lives today through vital services and support. MSAA provides numerous programs and services at no cost including: a Helpline with trained specialists; award-winning publications, including, The Motivator magazine; educational videos, webinars, and research updates; a mobile phone app, My MS Manager™; safety and mobility equipment products; cooling accessories for heat-sensitive individuals; My MSAA Community, a peer-to-peer online support forum; MS Conversations blog; a clinical trial search tool; podcasts; and more. For additional information, please visit www.mymsaa.org or call (800) 532-7667.
About Multiple Sclerosis Multiple sclerosis (MS) is a disease of the central nervous system (CNS), which consists of the brain, optic nerves, and spinal cord. MS damages or destroys the protective covering (known as myelin) surrounding the nerves of the CNS and can potentially injure the nerves as well. This damage causes reduced communication between the brain and nerve pathways. Common MS symptoms include visual problems, overwhelming fatigue, difficulty with balance and coordination, depression and cognitive issues, and various levels of impaired mobility. The prevalence of multiple sclerosis is estimated at nearly one million people nationwide and most people with MS are diagnosed between the ages of 20 and 50. Researchers continue to learn more as they look for both a cause and a cure.
View original content to download multimedia:https://www.prnewswire.com/news-releases/access-free-educational-videos-and-webinars-provided-by-the-multiple-sclerosis-association-of-america-302491197.html
SOURCE Multiple Sclerosis Association of America
擷取數據時發生錯誤
登入存取你的投資組合
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
擷取數據時發生錯誤
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Equazen® Reaffirms Its Commitment to Uncompromising Quality and Sustainability in Omegas Supplements
Equazen® continues to set the benchmark for excellence at every step of the value chain. LUGANO, Switzerland, June 26, 2025--(BUSINESS WIRE)--SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, highlights today its ongoing commitment to delivering the highest standard of quality for Equazen®, the company's global science-based food supplement brand designed to nourish, enhance and support the brain's potential. At SFI Health™, quality is more than a requirement—it is a mission. The company is committed to enhancing people's well-being by developing natural supplements that combine passion for nature-based healthcare, science, state-of-the-art production standards and sustainability, from ingredient sourcing to the final product reaching the patient. In particular, with over 25 years of trust built across multiple markets, Equazen®'s excellence is built on five core pillars: Ingredients Sourcing: Equazen®'s story begins in the sea, with responsibly sourced fish oil rich in essential Omega-3 fatty acids EPA and DHA, paired with cold-pressed evening primrose and borage seeds oils for Omega-6 (GLA). Every ingredient is carefully selected from certified suppliers, processed using validated methods ensuring purity and safety as well as full traceability in compliance with European Pharmacopoeia regulations. Besides, Equazen® suppliers are part of the IFFO, the international marine ingredients organization, promoting responsible sourcing and high-quality manufacturing in the industry of fish oil. Manufacturing & Supply Chain: Equazen® is produced under strict GMP standards, with each fish oil batch undergoing rigorous quality testing. All manufacturers adhere to recognized food safety systems, including HACCP and FDA registration. The supply chain is equally controlled—from packaging to transport—to protect product integrity till it reaches consumers. In addition, Equazen®'s suppliers are members of GOED (Global Organization for EPA and DHA Omega-3s), a respected international association setting high ethical and quality standards for the Omega-3 industry. Science-backed innovation: Equazen® products feature a unique and carefully balanced combination of essential fatty acids (Omega 3 and Omega 6), designed to support cognitive needs. Since its inception in 1999, Equazen® products' benefits for the human brain have been proven in over 15 pre-clinical and clinical investigations. In addition, ongoing collaborations with global experts and research institutions further strengthen the scientific foundation. Customer focus: Understanding and responding to consumer needs is key to Equazen®'s success. Feedback from parents, healthcare professionals, and consumers shapes product development and ongoing support. The brand also offers personalized guidance and educational resources to optimize usage. Sustainability: Equazen® also prioritizes environmental responsibility with sustainable production processes designed to minimize environmental impact. Its fish oil is sourced from regulated, sustainable fisheries and is a by-product of the fishmeal industry—ensuring no additional fish are caught for production. In addition, Equazen® fish oils are certified by Friends of the Sea®, a globally recognized independent body guaranteeing responsible sourcing, full traceability, and environmental stewardship. "Our mission with Equazen® is to provide natural supplements that parents and caregivers can trust to support cognitive needs and the health of human brain," said Matthew Brabazon, General Manager at SFI Health™ EMEA. "This is made possible only through ethical sourcing, advanced manufacturing, and robust scientific validation." As market demands evolve, Equazen® remains dedicated to pushing quality standards further at every step of the value chain to offer best-in-class solutions for optimal cognitive health. Consumers can trust that every product reflects a passion for health, innovation, and sustainability. About SFI Health™ SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing. Guided by the belief in the healing potential of natural products, SFI Health™ combines a rigorous pharma-based approach with the benefits of naturally sourced solutions. An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa. SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide. For more information, go to or follow us SFI Health on LinkedIn. About Equazen® Equazen® is a science-based globally branded food supplement designed and studied to help nourish, enhance, and support the human brain's potential across all life stages. Each product of the Equazen® range contains a balanced unique combination of essential fatty acids (Omega-3 and Omega-6), which has been clinically proven for more than 20 years to assist with learning capabilities, concentration and healthy brain development. Equazen® is available in multiple pharmaceutical formats and sizes to support optimal cognitive functions from infants to teenagers. Currently marketed in 30 countries globally, Equazen® is widely recommended by healthcare professionals and trusted by families for the last 25 years. Equazen® aims to advance human health naturally, delivering expertly formulated products that empower individuals to reach their cognitive potential. For more info visit View source version on Contacts For more informationSFI Health™ EMEA Contact Elisabetta Bianchie-mail address: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
an hour ago
- Business Wire
Equazen ® Reaffirms Its Commitment to Uncompromising Quality and Sustainability in Omegas Supplements
LUGANO, Switzerland--(BUSINESS WIRE)--SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, highlights today its ongoing commitment to delivering the highest standard of quality for Equazen ®, the company's global science-based food supplement brand designed to nourish, enhance and support the brain's potential. 'Our mission with Equazen® is to provide natural supplements that parents and caregivers can trust to support cognitive needs. This is made possible only through ethical sourcing, advanced manufacturing, and robust scientific validation." Matthew Brabazon Share At SFI Health™, quality is more than a requirement—it is a mission. The company is committed to enhancing people's well-being by developing natural supplements that combine passion for nature-based healthcare, science, state-of-the-art production standards and sustainability, from ingredient sourcing to the final product reaching the patient. In particular, with over 25 years of trust built across multiple markets, Equazen ® 's excellence is built on five core pillars: Ingredients Sourcing: Equazen ® 's story begins in the sea, with responsibly sourced fish oil rich in essential Omega-3 fatty acids EPA and DHA, paired with cold-pressed evening primrose and borage seeds oils for Omega-6 (GLA). Every ingredient is carefully selected from certified suppliers, processed using validated methods ensuring purity and safety as well as full traceability in compliance with European Pharmacopoeia regulations. Besides, Equazen ® suppliers are part of the IFFO, the international marine ingredients organization, promoting responsible sourcing and high-quality manufacturing in the industry of fish oil. Manufacturing & Supply Chain: Equazen ® is produced under strict GMP standards, with each fish oil batch undergoing rigorous quality testing. All manufacturers adhere to recognized food safety systems, including HACCP and FDA registration. The supply chain is equally controlled—from packaging to transport—to protect product integrity till it reaches consumers. In addition, Equazen ® 's suppliers are members of GOED (Global Organization for EPA and DHA Omega-3s), a respected international association setting high ethical and quality standards for the Omega-3 industry. Science-backed innovation: Equazen ® products feature a unique and carefully balanced combination of essential fatty acids (Omega 3 and Omega 6), designed to support cognitive needs. Since its inception in 1999, Equazen ® products' benefits for the human brain have been proven in over 15 pre-clinical and clinical investigations. In addition, ongoing collaborations with global experts and research institutions further strengthen the scientific foundation. Customer focus: Understanding and responding to consumer needs is key to Equazen ® 's success. Feedback from parents, healthcare professionals, and consumers shapes product development and ongoing support. The brand also offers personalized guidance and educational resources to optimize usage. Sustainability: Equazen ® also prioritizes environmental responsibility with sustainable production processes designed to minimize environmental impact. Its fish oil is sourced from regulated, sustainable fisheries and is a by-product of the fishmeal industry—ensuring no additional fish are caught for production. In addition, Equazen ® fish oils are certified by Friends of the Sea ®, a globally recognized independent body guaranteeing responsible sourcing, full traceability, and environmental stewardship. 'Our mission with Equazen ® is to provide natural supplements that parents and caregivers can trust to support cognitive needs and the health of human brain,' said Matthew Brabazon, General Manager at SFI Health™ EMEA. 'This is made possible only through ethical sourcing, advanced manufacturing, and robust scientific validation.' As market demands evolve, Equazen ® remains dedicated to pushing quality standards further at every step of the value chain to offer best-in-class solutions for optimal cognitive health. Consumers can trust that every product reflects a passion for health, innovation, and sustainability. About SFI Health™ SFI Health™ is a global leader in natural healthcare, specialized in the design, development and commercialization of clinically researched products in the areas of microbiome, cognition and wellbeing. Guided by the belief in the healing potential of natural products, SFI Health™ combines a rigorous pharma-based approach with the benefits of naturally sourced solutions. An extensive network of trusted business partners enables the company, headquartered in Australia, to market its own brands, reaching consumers in over 50 countries. The EMEA SFI Health™ regional office in Lugano, Switzerland, manages commercial operations across Europe, Middle East and Africa. SFI Health™ is committed to fostering confidence in natural healthcare by sharing state-of-the-art research, technical expertise and comprehensive sales & marketing resources with consumers, healthcare professionals and partners worldwide. For more information, go to or follow us SFI Health on LinkedIn. About Equazen ® Equazen ® is a science-based globally branded food supplement designed and studied to help nourish, enhance, and support the human brain's potential across all life stages. Each product of the Equazen ® range contains a balanced unique combination of essential fatty acids (Omega-3 and Omega-6), which has been clinically proven for more than 20 years to assist with learning capabilities, concentration and healthy brain development. Equazen ® is available in multiple pharmaceutical formats and sizes to support optimal cognitive functions from infants to teenagers. Currently marketed in 30 countries globally, Equazen ® is widely recommended by healthcare professionals and trusted by families for the last 25 years. Equazen ® aims to advance human health naturally, delivering expertly formulated products that empower individuals to reach their cognitive potential.


Business Upturn
9 hours ago
- Business Upturn
Amesite's HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses
By GlobeNewswire Published on June 26, 2025, 01:43 IST DETROIT, June 25, 2025 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced that its flagship app, NurseMagic™, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) — accounting for 19.2% of the nursing workforce — and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States : Nearly 20% of U.S. nurses have English as a Second Language (ESL) : Nearly 20% of U.S. nurses have English as a Second Language (ESL) International healthcare systems treating U.S. patients : There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone. : There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone. Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO. Madison Bush, Director of Corporate Operations, said, 'This rollout reflects our disciplined approach to targeting segments with clear, documented needs — including the nearly one in five nurses in the U.S. who speak English as a second language. By addressing the needs of this workforce, who must document in English, we're positioned to capture value domestically and expand internationally.' Sai Nittala, Senior AI Manager, said, 'NurseMagic™ V3.0 delivers healthcare charting solutions that outperform generic, off-the-shelf AI tools. Unlike many unregulated or non-integrated solutions, NurseMagic™ is designed for seamless integration into critical healthcare workflows — where compliance, accuracy, and efficiency are essential. Our multilingual capability underscores our ability to scale rapidly while meeting real-world needs.'' Dr. Ann Marie Sastry, Founder & CEO, said, 'We have growing B2B traction following our launch of enterprise administration tools, and are also supporting B2C growth in new segments that prepare us for global expansion. As reported in our Q3 2025 10‑Q, we achieved a 2.4× quarter-on-quarter revenue increase while continuing to cut operating expenses. We believe we're on track for further revenue growth and cost efficiencies in coming quarters.' NurseMagic™ is Now Available In: English, Chinese, Hindi, Spanish, French, Portuguese, Russian, Indonesian, German, Japanese, Korean, Turkish, Italian, Ukrainian, Dutch, Swedish. Amesite recently announced a 2.4x quarter-over-quarter revenue increase in its 10-Q filing, driven by rapid adoption of its NurseMagic™ platform and improvements in operating efficiency. The company also launched a higher-priced enterprise tier in response to growing B2B demand for more capacity. In April, Amesite reported that NurseMagic™ meets HIPAA requirements for individual users and enterprises, enabling secure documentation of protected health information across all user types. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'believe,' 'intend,' 'look forward,' and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations [email protected] Sources Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.